End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

MLA

Berges, Raphael, et al. “End-Binding 1 Protein Overexpression Correlates with Glioblastoma Progression and Sensitizes to Vinca-Alkaloids in Vitro and in Vivo.” Oncotarget, vol. 5, no. 24, Dec. 2014, pp. 12769–87. EBSCOhost, https://doi.org/10.18632/oncotarget.2646.

APA

Berges, R., Baeza-Kallee, N., Tabouret, E., Chinot, O., Petit, M., Kruczynski, A., Figarella-Branger, D., Honore, S., & Braguer, D. (2014). End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo. Oncotarget, 5(24), 12769–12787. https://doi.org/10.18632/oncotarget.2646

Chicago

Berges, Raphael, Nathalie Baeza-Kallee, Emeline Tabouret, Olivier Chinot, Marie Petit, Anna Kruczynski, Dominique Figarella-Branger, Stephane Honore, and Diane Braguer. 2014. “End-Binding 1 Protein Overexpression Correlates with Glioblastoma Progression and Sensitizes to Vinca-Alkaloids in Vitro and in Vivo.” Oncotarget 5 (24): 12769–87. doi:10.18632/oncotarget.2646.